Cargando…
Novel factor VIII variants with a modified furin cleavage site improve the efficacy of gene therapy for hemophilia A
ESSENTIALS: Factor (F) VIII is an inefficiently expressed protein. Furin deletion FVIII variants were purified and characterized using in vitro and in vivo assays. These minimally modified novel FVIII variants have enhanced function. These variants provide a strategy for increasing FVIII expression...
Autores principales: | Nguyen, G. N., George, L. A., Siner, J. I., Davidson, R. J., Zander, C. B., Zheng, X. L., Arruda, V. R., Camire, R. M., Sabatino, D. E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5280213/ https://www.ncbi.nlm.nih.gov/pubmed/27749002 http://dx.doi.org/10.1111/jth.13543 |
Ejemplares similares
-
Biochemical and functional characterization of a recombinant monomeric factor VIII–Fc fusion protein
por: PETERS, R T, et al.
Publicado: (2013) -
Identification of aggregates in therapeutic formulations of recombinant full‐length factor VIII products by sedimentation velocity analytical ultracentrifugation
por: Healey, J. F., et al.
Publicado: (2018) -
Novel, high incidence exercise-induced muscle bleeding model in hemophilia B mice: rationale, development and prophylactic intervention
por: Tranholm, M, et al.
Publicado: (2015) -
A viable mouse model of factor X deficiency provides evidence for maternal transfer of factor X
por: TAI, S J, et al.
Publicado: (2008) -
An engineered U1 small nuclear RNA rescues splicing-defective coagulation F7 gene expression in mice
por: Balestra, D, et al.
Publicado: (2014)